Validating a composite endpoint for acceptability evaluation of oral drug formulations in the pediatric population: a randomized, open-label, single dose, cross-over study

医学 适口性 临床终点 人口 临床试验 儿科 内科学 环境卫生 病理
作者
Juliane Münch,Anna Lena Schwarzwälder,Carolin Kloft,Hans Martin Bosse,Manfred Wargenau,Sibylle Reidemeister,Ingrid Klingmann,Viviane Klingmann
出处
期刊:Frontiers in Pharmacology [Frontiers Media]
卷期号:15: 1436554-1436554 被引量:9
标识
DOI:10.3389/fphar.2024.1436554
摘要

Objective: This study aimed to validate the newly developed composite acceptability endpoint to investigate acceptability of oral pediatric drug formulations that integrates swallowability and palatability assessments. Methods: In this open-label study acceptability of oral formulations was tested in three age groups (1-<6 months, 6-<12 years, and 12-<18 years) with a 2-way cross-over design in children aged 1-<6 months (syrup and mini-tablets), and with an incomplete block design of four sequences with three out of four formulations (syrup, mini-tablets, oblong tablet, and round tablet) each in children aged 6-<18 years. The primary endpoint was acceptability derived from the composite acceptability endpoint. Secondary endpoints were palatability and acceptability derived from swallowability. Results: A total of 320 children were stratified into three age groups (80 children aged 1-<6 months, 120 children aged 6-<12 years, and 120 children aged 12-<18 years). All participants completed the study. Age-specific differences were observed in acceptability derived from the composite acceptability endpoint. Mini-tablets had the highest acceptability in participants aged 1-<6 months and 6-<12 years while the oblong tablet was leading in adolescent participants (12-<18 years). Conclusion: This study demonstrated that the composite acceptability endpoint method integrating both swallowability and palatability assessments is a sensitive method to assess acceptability of drug formulations in children of different age. Clinical Trial Registration: https://drks.de/search/de, identifier DRKS00027948.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
鸟窝的应助被大聪明采纳,获得10
刚刚
守得云开见月明完成签到 ,获得积分10
1秒前
1秒前
1秒前
张星星发布了新的文献求助10
1秒前
vivi发布了新的文献求助10
1秒前
超级玛丽完成签到,获得积分10
3秒前
3秒前
初景发布了新的文献求助10
3秒前
jjjj佳发布了新的文献求助10
4秒前
打打的应助被香蕉梨愁采纳,获得10
4秒前
杨钧贺发布了新的文献求助20
5秒前
娇妹儿发布了新的文献求助10
6秒前
6秒前
7秒前
jj发布了新的文献求助10
8秒前
8秒前
Milktea123完成签到,获得积分10
8秒前
10秒前
顺心曼雁发布了新的文献求助10
11秒前
12秒前
酷波er的应助被武切维奇采纳,获得10
12秒前
Akim的应助被YutingLiu0101采纳,获得10
13秒前
科研通AI6.2的应助被和平发展采纳,获得100
13秒前
Juvenilesy的应助被sirius采纳,获得10
13秒前
朱成豪发布了新的文献求助10
14秒前
王大帅哥完成签到,获得积分10
14秒前
NexusExplorer的应助被bluee采纳,获得10
14秒前
等待的小鸽子完成签到,获得积分10
14秒前
YunjiangZhang发布了新的文献求助10
15秒前
Hello的应助被zhaopeng采纳,获得10
15秒前
陈博逊发布了新的文献求助10
15秒前
18秒前
18秒前
18秒前
海洲完成签到,获得积分10
18秒前
18秒前
Savananh_Xie发布了新的文献求助30
19秒前
19秒前
可爱的函函的应助被大聪明采纳,获得10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Markov Decision Processes and Reinforcement Learning 700
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8171039
求助须知:如何正确求助?哪些是违规求助? 9563751
关于积分的说明 21772122
捐赠科研通 7762548
什么是DOI,文献DOI怎么找? 3430786
关于科研通互助平台的介绍 2554676
邀请新用户注册赠送积分活动 2475657